Reviews Copegus


No reviews yet.

Copegus Drug Description
COPEGUS®
(ribavirin, USP) Tablets


COPEGUS (ribavirin) monotherapy is not effective for the treatment of chronic
hepatitis C virus infection and should not be used alone for this indication
(see WARNINGS).
The primary clinical toxicity of ribavirin is hemolytic anemia. The anemia
associated with ribavirin therapy may result in worsening of cardiac disease
that has led to fatal and nonfatal myocardial infarctions. Patients with a history
of significant or unstable cardiac disease should not be treated with ribavirin
(see WARNINGS, ADVERSE REACTIONS, and DOSAGE AND ADMINISTRATION).
Significant teratogenic and/or embryocidal effects have been demonstrated
in all animal species exposed to ribavirin. In addition, ribavirin has a multiple
dose half-life of 12 days, and it may persist in non-plasma compartments for
as long as 6 months. Ribavirin therapy is contraindicated in women who are pregnant
and in the male partners of women who are pregnant. Extreme care must be taken
to avoid pregnancy during therapy and for 6 months after completion of therapy
in both female patients and in female partners of male patients who are taking
ribavirin therapy. At least two reliable forms of effective contraception must
be utilized during treatment and during the 6-month posttreatment follow-up
period (see CONTRAINDICATIONS, WARNINGS, and PATIENT INFORMATION,
and PRECAUTIONS: Pregnancy: Category X).

DRUG DESCRIPTION



What are the possible side effects of ribavirin (Copegus, Rebetol, RibaPak, Ribasphere, RibaTab)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using ribavirin and call your doctor at once if you have any of these serious side effects:

pale or yellowed skin, dark colored urine, easy bruising or bleeding, confusion, or unusual weakness;
severe depression, hallucinations, thoughts of suicide or hurting yourself;
...
Read All Potential Side Effects for Copegus »




COPEGUS, ribavirin, is a nucleoside analogue with antiviral activity. The chemical
name of ribavirin is 1-β-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide
and has the following structural formula:








The empirical formula of ribavirin is C8H12N4O5
and the molecular weight is 244.2. Ribavirin is a white to off-white powder.
It is freely soluble in water and slightly soluble in anhydrous alcohol.
COPEGUS (ribavirin) is available as a light pink to pink colored, flat, oval-shaped, film-coated tablet for oral administration. Each tablet contains 200 mg of ribavirin and the following inactive ingredients: pregelatinized starch, microcrystalline cellulose, sodium starch glycolate, cornstarch, and magnesium stearate. The coating of the tablet contains Chromatone-P® or Opadry® Pink (made by using hydroxypropyl methyl cellulose, talc, titanium dioxide, synthetic yellow iron oxide, and synthetic red iron oxide), ethyl cellulose (ECD-30), and triacetin.
Mechanism of Action
Ribavirin is a synthetic nucleoside analogue. The mechanism by which the combination of ribavirin and an interferon product exerts its effects against the hepatitis C virus has not been fully established.
Last reviewed on RxList: 7/1/2010




Copegus Drug Description
COPEGUS®
(ribavirin, USP) Tablets


COPEGUS (ribavirin) monotherapy is not effective for the treatment of chronic
hepatitis C virus infection and should not be used alone for this indication
(see WARNINGS).
The primary clinical toxicity of ribavirin is hemolytic anemia. The anemia
associated with ribavirin therapy may result in worsening of cardiac disease
that has led to fatal and nonfatal myocardial infarctions. Patients with a history
of significant or unstable cardiac disease should not be treated with ribavirin
(see WARNINGS, ADVERSE REACTIONS, and DOSAGE AND ADMINISTRATION).
Significant teratogenic and/or embryocidal effects have been demonstrated
in all animal species exposed to ribavirin. In addition, ribavirin has a multiple
dose half-life of 12 days, and it may persist in non-plasma compartments for
as long as 6 months. Ribavirin therapy is contraindicated in women who are pregnant
and in the male partners of women who are pregnant. Extreme care must be taken
to avoid pregnancy during therapy and for 6 months after completion of therapy
in both female patients and in female partners of male patients who are taking
ribavirin therapy. At least two reliable forms of effective contraception must
be utilized during treatment and during the 6-month posttreatment follow-up
period (see CONTRAINDICATIONS, WARNINGS, and PATIENT INFORMATION,
and PRECAUTIONS: Pregnancy: Category X).

DRUG DESCRIPTION



What are the possible side effects of ribavirin (Copegus, Rebetol, RibaPak, Ribasphere, RibaTab)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using ribavirin and call your doctor at once if you have any of these serious side effects:

pale or yellowed skin, dark colored urine, easy bruising or bleeding, confusion, or unusual weakness;
severe depression, hallucinations, thoughts of suicide or hurting yourself;
...
Read All Potential Side Effects for Copegus »




COPEGUS, ribavirin, is a nucleoside analogue with antiviral activity. The chemical
name of ribavirin is 1-β-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide
and has the following structural formula:








The empirical formula of ribavirin is C8H12N4O5
and the molecular weight is 244.2. Ribavirin is a white to off-white powder.
It is freely soluble in water and slightly soluble in anhydrous alcohol.
COPEGUS (ribavirin) is available as a light pink to pink colored, flat, oval-shaped, film-coated tablet for oral administration. Each tablet contains 200 mg of ribavirin and the following inactive ingredients: pregelatinized starch, microcrystalline cellulose, sodium starch glycolate, cornstarch, and magnesium stearate. The coating of the tablet contains Chromatone-P® or Opadry® Pink (made by using hydroxypropyl methyl cellulose, talc, titanium dioxide, synthetic yellow iron oxide, and synthetic red iron oxide), ethyl cellulose (ECD-30), and triacetin.
Mechanism of Action
Ribavirin is a synthetic nucleoside analogue. The mechanism by which the combination of ribavirin and an interferon product exerts its effects against the hepatitis C virus has not been fully established.
Last reviewed on RxList: 7/1/2010




Copegus Drug Description
COPEGUS®
(ribavirin, USP) Tablets


COPEGUS (ribavirin) monotherapy is not effective for the treatment of chronic
hepatitis C virus infection and should not be used alone for this indication
(see WARNINGS).
The primary clinical toxicity of ribavirin is hemolytic anemia. The anemia
associated with ribavirin therapy may result in worsening of cardiac disease
that has led to fatal and nonfatal myocardial infarctions. Patients with a history
of significant or unstable cardiac disease should not be treated with ribavirin
(see WARNINGS, ADVERSE REACTIONS, and DOSAGE AND ADMINISTRATION).
Significant teratogenic and/or embryocidal effects have been demonstrated
in all animal species exposed to ribavirin. In addition, ribavirin has a multiple
dose half-life of 12 days, and it may persist in non-plasma compartments for
as long as 6 months. Ribavirin therapy is contraindicated in women who are pregnant
and in the male partners of women who are pregnant. Extreme care must be taken
to avoid pregnancy during therapy and for 6 months after completion of therapy
in both female patients and in female partners of male patients who are taking
ribavirin therapy. At least two reliable forms of effective contraception must
be utilized during treatment and during the 6-month posttreatment follow-up
period (see CONTRAINDICATIONS, WARNINGS, and PATIENT INFORMATION,
and PRECAUTIONS: Pregnancy: Category X).

DRUG DESCRIPTION



What are the possible side effects of ribavirin (Copegus, Rebetol, RibaPak, Ribasphere, RibaTab)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using ribavirin and call your doctor at once if you have any of these serious side effects:

pale or yellowed skin, dark colored urine, easy bruising or bleeding, confusion, or unusual weakness;
severe depression, hallucinations, thoughts of suicide or hurting yourself;
...
Read All Potential Side Effects for Copegus »




COPEGUS, ribavirin, is a nucleoside analogue with antiviral activity. The chemical
name of ribavirin is 1-β-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide
and has the following structural formula:








The empirical formula of ribavirin is C8H12N4O5
and the molecular weight is 244.2. Ribavirin is a white to off-white powder.
It is freely soluble in water and slightly soluble in anhydrous alcohol.
COPEGUS (ribavirin) is available as a light pink to pink colored, flat, oval-shaped, film-coated tablet for oral administration. Each tablet contains 200 mg of ribavirin and the following inactive ingredients: pregelatinized starch, microcrystalline cellulose, sodium starch glycolate, cornstarch, and magnesium stearate. The coating of the tablet contains Chromatone-P® or Opadry® Pink (made by using hydroxypropyl methyl cellulose, talc, titanium dioxide, synthetic yellow iron oxide, and synthetic red iron oxide), ethyl cellulose (ECD-30), and triacetin.
Mechanism of Action
Ribavirin is a synthetic nucleoside analogue. The mechanism by which the combination of ribavirin and an interferon product exerts its effects against the hepatitis C virus has not been fully established.
Last reviewed on RxList: 7/1/2010




Copegus Drug Description
COPEGUS®
(ribavirin, USP) Tablets


COPEGUS (ribavirin) monotherapy is not effective for the treatment of chronic
hepatitis C virus infection and should not be used alone for this indication
(see WARNINGS).
The primary clinical toxicity of ribavirin is hemolytic anemia. The anemia
associated with ribavirin therapy may result in worsening of cardiac disease
that has led to fatal and nonfatal myocardial infarctions. Patients with a history
of significant or unstable cardiac disease should not be treated with ribavirin
(see WARNINGS, ADVERSE REACTIONS, and DOSAGE AND ADMINISTRATION).
Significant teratogenic and/or embryocidal effects have been demonstrated
in all animal species exposed to ribavirin. In addition, ribavirin has a multiple
dose half-life of 12 days, and it may persist in non-plasma compartments for
as long as 6 months. Ribavirin therapy is contraindicated in women who are pregnant
and in the male partners of women who are pregnant. Extreme care must be taken
to avoid pregnancy during therapy and for 6 months after completion of therapy
in both female patients and in female partners of male patients who are taking
ribavirin therapy. At least two reliable forms of effective contraception must
be utilized during treatment and during the 6-month posttreatment follow-up
period (see CONTRAINDICATIONS, WARNINGS, and PATIENT INFORMATION,
and PRECAUTIONS: Pregnancy: Category X).

DRUG DESCRIPTION



What are the possible side effects of ribavirin (Copegus, Rebetol, RibaPak, Ribasphere, RibaTab)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using ribavirin and call your doctor at once if you have any of these serious side effects:

pale or yellowed skin, dark colored urine, easy bruising or bleeding, confusion, or unusual weakness;
severe depression, hallucinations, thoughts of suicide or hurting yourself;
...
Read All Potential Side Effects for Copegus »




COPEGUS, ribavirin, is a nucleoside analogue with antiviral activity. The chemical
name of ribavirin is 1-β-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide
and has the following structural formula:








The empirical formula of ribavirin is C8H12N4O5
and the molecular weight is 244.2. Ribavirin is a white to off-white powder.
It is freely soluble in water and slightly soluble in anhydrous alcohol.
COPEGUS (ribavirin) is available as a light pink to pink colored, flat, oval-shaped, film-coated tablet for oral administration. Each tablet contains 200 mg of ribavirin and the following inactive ingredients: pregelatinized starch, microcrystalline cellulose, sodium starch glycolate, cornstarch, and magnesium stearate. The coating of the tablet contains Chromatone-P® or Opadry® Pink (made by using hydroxypropyl methyl cellulose, talc, titanium dioxide, synthetic yellow iron oxide, and synthetic red iron oxide), ethyl cellulose (ECD-30), and triacetin.
Mechanism of Action
Ribavirin is a synthetic nucleoside analogue. The mechanism by which the combination of ribavirin and an interferon product exerts its effects against the hepatitis C virus has not been fully established.
Last reviewed on RxList: 7/1/2010




Copegus Drug Description
COPEGUS®
(ribavirin, USP) Tablets


COPEGUS (ribavirin) monotherapy is not effective for the treatment of chronic
hepatitis C virus infection and should not be used alone for this indication
(see WARNINGS).
The primary clinical toxicity of ribavirin is hemolytic anemia. The anemia
associated with ribavirin therapy may result in worsening of cardiac disease
that has led to fatal and nonfatal myocardial infarctions. Patients with a history
of significant or unstable cardiac disease should not be treated with ribavirin
(see WARNINGS, ADVERSE REACTIONS, and DOSAGE AND ADMINISTRATION).
Significant teratogenic and/or embryocidal effects have been demonstrated
in all animal species exposed to ribavirin. In addition, ribavirin has a multiple
dose half-life of 12 days, and it may persist in non-plasma compartments for
as long as 6 months. Ribavirin therapy is contraindicated in women who are pregnant
and in the male partners of women who are pregnant. Extreme care must be taken
to avoid pregnancy during therapy and for 6 months after completion of therapy
in both female patients and in female partners of male patients who are taking
ribavirin therapy. At least two reliable forms of effective contraception must
be utilized during treatment and during the 6-month posttreatment follow-up
period (see CONTRAINDICATIONS, WARNINGS, and PATIENT INFORMATION,
and PRECAUTIONS: Pregnancy: Category X).

DRUG DESCRIPTION



What are the possible side effects of ribavirin (Copegus, Rebetol, RibaPak, Ribasphere, RibaTab)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using ribavirin and call your doctor at once if you have any of these serious side effects:

pale or yellowed skin, dark colored urine, easy bruising or bleeding, confusion, or unusual weakness;
severe depression, hallucinations, thoughts of suicide or hurting yourself;
...
Read All Potential Side Effects for Copegus »




COPEGUS, ribavirin, is a nucleoside analogue with antiviral activity. The chemical
name of ribavirin is 1-β-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide
and has the following structural formula:








The empirical formula of ribavirin is C8H12N4O5
and the molecular weight is 244.2. Ribavirin is a white to off-white powder.
It is freely soluble in water and slightly soluble in anhydrous alcohol.
COPEGUS (ribavirin) is available as a light pink to pink colored, flat, oval-shaped, film-coated tablet for oral administration. Each tablet contains 200 mg of ribavirin and the following inactive ingredients: pregelatinized starch, microcrystalline cellulose, sodium starch glycolate, cornstarch, and magnesium stearate. The coating of the tablet contains Chromatone-P® or Opadry® Pink (made by using hydroxypropyl methyl cellulose, talc, titanium dioxide, synthetic yellow iron oxide, and synthetic red iron oxide), ethyl cellulose (ECD-30), and triacetin.
Mechanism of Action
Ribavirin is a synthetic nucleoside analogue. The mechanism by which the combination of ribavirin and an interferon product exerts its effects against the hepatitis C virus has not been fully established.
Last reviewed on RxList: 7/1/2010





Other reviews about Copegus on wordpress

Pharmasset says hepatitis C drug meets trial goals
  by Sans
10th September 2007By Sarah RoutledgePharmasset has reported preliminary safety and potent antiviral activity with its investigational drug following 14 days of monotherapy in 40 patients chronically infected with […]


Pharmasset, Inc. (Nasdaq: VRUS)-3 Agents in the Pipeline.
  by stockmd
  Pharmasset (VRUS:Nasdaq) is a pharmaceutical company geared towards developing oral treatments for chronic viral infections.  At this time the company is focusing on agents directed against Hepatitis B, C as […]


What If We Fail "The Test"?
  by Ron
Roger Kimball comments on Professor Barry's career at the University of Chicago Law School: There is probably a lot one could say about the piece The New York Times […]


"Do You Read the New York Times?"
  by Ron
Douglas Mackinnon on Nixon: The Hollywood Version: ...Recently, here in Washington, [movie director Ron] Howard offered up a screening of [his] film [Frost/Nixon] at the headquarters of the National […]


Back in Business
  by bavonww
Well, after my brief resurgence to post those Wigwam lyrics (hilarious!) I went into a bit of a decline. Seem to be hovering at a level of 'feeling […]


Still in Business
  by bavonww
21:20 Pm 05/09/09   Gordon Brown is a traitor in league with Islam as evidenced by his dealings with Libya Rapist/Killer who is a hysterical hedonist gets preferrential treatment, typical of our […]


History of Hep C
  by hephopdeluxe
A Brief History of Hepatitis C Alan Franciscus, Editor-in-Chief The management and care of hepatitis C has come a […]


Partnership between InterMune and Roche scores trial success
  by silico
Shares in InterMune rose strongly on the success of a mid-stage trial of its hepatitis C candidate danoprevir, which is being developed with Roche. Danoprevir is being assessed […]


Hepatitis C - Drug Pipeline Analysis and Market Forecasts to 2016
  by reportsnreports
Hepatitis C - Drug Pipeline Analysis and Market Forecasts to 2016 Summary GlobalData has released a pharmaceutical and healthcare report, “Hepatitis C - Drug Pipeline Analysis and […]


Hepatitis C (HCV) – Pipeline Assessment and Market Forecasts to 2016 now available at ReportsandReports
  by reportsnreports
Dallas, ReportsandReports Announce it Will Carry Hepatitis C (HCV) – Pipeline Assessment and Market Forecasts to 2016 Market Research Report in its Store. Browse the complete Report on: http://www.reportsandreports.com/market-reports/hepatitis-c-hcv-pipeline-assessment-and-market-forecasts-to-2/ GlobalData, the […]



Other reviews about Copegus on web:

Learn about the prescription medication Copegus (Ribavirin), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Copegus (Ribavirin) Drug Information: Uses, Side Effects, Drug ...


1 COPEGUS ® 1 (ribavirin, USP) 2 TABLETS 3 R x only 4 COPEGUS (ribavirin) monotherapy is not effective for the treatment of chronic 5 hepatitis C virus infection and should not be used alone ... COPEGUS® (ribavirin, USP) TABLETS


Accurate, FDA approved Copegus information for healthcare professionals and patients - brought to you by Drugs.com. Copegus Official FDA information, side effects and uses.


Read about COPEGUS, a medication that is used in combination with PEGASYS to help fight the hepatitis C virus. COPEGUS® (Ribavirin, USP) & PEGASYS® (Peginterferon alfa-2a)—HCV


All about Copegus Tablets. View complete and up to date Copegus information - part of the Drugs.com trusted medication database. Copegus Tablets Facts and Comparisons at Drugs.com


Pegasys Full Prescribing Information and Medication Guide (505K/PDF) Pegasys Medication Guide (260K/PDF) Copegus Full Prescribing Information and Medication Guide (223K/PDF) Genentech: Medicines: Pegasys


Consumer information about the medication RIBAVIRIN - ORAL TABLETS (Copegus), includes side effects, drug interactions, recommended dosages, and storage information. Read more ... RIBAVIRIN - ORAL TABLETS (Copegus) side effects, medical uses, and ...


COPEGUS can also be used in patients coinfected with hepatitis C and HIV. Do not take COPEGUS by itself. Most Serious Side Effects for COPEGUS Hepatitis C Treatment-PEGASYS® (Peginterferon alfa-2a)


Ribavirin (brand names: Copegus, Rebetol, Ribasphere, Vilona and Virazole) is an anti-viral drug indicated for severe RSV infection (individually), hepatitis C infection (used in ... Ribavirin - Wikipedia, the free encyclopedia


Buy Copegus (Ribavirin) from our Canadian Online Pharmacy by calling 1-877-888-3562. Fully licensed, fast delivery, free doctor consultation provided. Buy Copegus (Ribavirin) Online Now





Featured Reviews

Reviews Derma-Smoothe/FS

Derma-Smoothe/FS Drug Description Derma-Smoothe/FS® (fluocinolone acetonide) Topical Oil, 0.01% (Body Oil) For topical use only DRUG DESCRIPTION What are the possible side effects of fluocinolone topical oil (Derma-Smoothe/FS)? Get...
Read More  |  Review This
Reviews Anectine

Anectine Drug Description ANECTINE® (succinylcholine chloride) Injection, USP WARNING RISK OF CARDIAC ARREST FROM HYPERKALEMIC RHABDOMYOLYSIS There have been rare reports of acute rhabdomyolysis with hyperkalemia followed by...
Read More  |  Review This
Reviews Minocycline Hydrochloride

Solodyn Drug Description SOLODYN® (minocycline HCl) Extended Release Tablets for Oral Use DRUG DESCRIPTION What are the possible side effects of minocycline (Dynacin, Minocin, Minocin PAC, Myrac, Solodyn)? Get emergency medical...
Read More  |  Review This
Reviews Norepinephrine Bitartrate

Levophed Drug Description LEVOPHED (norepinephrine bitartrate) Injection, Solution, Concentrate DRUG DESCRIPTION What are the possible side effects of norepinephrine (Levophed Bitartrate)? Get emergency medical help if you have...
Read More  |  Review This
Reviews Flector Patch

Flector Patch Drug Description FLECTOR (diclofenac epolamine) Patch Flector® Patch (diclofenac epolamine) Topical Patch 1.3% Cardiovascular Risk NSAIDs may cause an increased risk of serious cardiovascular thrombotic ...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....